Inhibition of gelatinase B (matrix metalloproteinase-9) by dihydrolipoic acid

Author： Cantin André M Martel Marc Drouin Geneviève Paquette Benoit

ISSN： 1205-7541

Source： Canadian Journal of Physiology and Pharmacology, Vol.83, Iss.3, 2005-03, pp. : 301-308

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Matrix Metalloproteinase-9/Gelatinase B is a Putative Therapeutic Target of Chronic Obstructive Pulmonary Disease and Multiple Sclerosis

Current Pharmaceutical Biotechnology, Vol. 9, Iss. 1, 2008-02 ,pp. : 34-46

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic developments in matrix metalloproteinase inhibition

By Shah Prediman K Wilkin Douglas J Doherty Terence M Uzui Hiroyasu Rajavashisth Tripathi B Asotra Kamlesh Pei Duanqing

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 5, 2002-05 ,pp. : 665-707

Informa Healthcare

Access to resources Recommend Favorite

A Bioinorganic Perspective on Matrix Metalloproteinase Inhibition

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 15, 2004-11 ,pp. : 1551-1573

Bentham Science Publishers

Access to resources Recommend Favorite

Matrix Metalloproteinase-9 and Airway Remodeling in Asthma

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 2, 2005-04 ,pp. : 177-181

Bentham Science Publishers

Access to resources Recommend Favorite

Osteopontin is proteolytically processed by matrix metalloproteinase 9

By Lindsey Merry L. Zouein Fouad A. Tian Yuan Padmanabhan Iyer Rugmani de Castro Brás Lisandra E.

Canadian Journal of Physiology and Pharmacology, Vol. 93, Iss. 10, 2015-01 ,pp. : 879-886

NRC Research Press

Access to resources Recommend Favorite